glp-1 degradation metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion | Diabetologia Mechanisms underlying the rapid degradation

Avoid referencing investigational or unapproved drugs in promotional materials

If youre considering any GLP-1 medication, start with a clinician who understands the science, not marketing hype

The American Society of Anesthesiologists recommends discussing GLP-1 cessation with your surgeon because these medications slow gastric emptyingthe rate at which food leaves your stomachwhich can complicate anesthesia and aspiration risk during general anesthesia

Continuing Therapy & Maintenance Phase Once the desired weight loss is achieved, the dosage may be further adjusted to maintain results

Quick Answer: GLP-1 medications typically cause modest blood pressure reductions of 2-6 mmHg, but some patients may experience symptomatic low blood pressure, particularly when combined with antihypertensive medications, significant weight loss, or dehydration from gastrointestinal side effects